Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Security class unavailable · CUSIP: 21077P108
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,000,000
- Percent of class
- 1.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002033916-24-000018
- Form type
- SC 13G
- Filer
- Context Therapeutics Inc.
- CIK
- CIK 1842952
- Filed
- Nov 06, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership